Medicxi raises €400m in latest fund to support EU biotech 31-Jul-2019 By Ben Hargreaves Medicxi announces the closure of its third fund, which generated €400m to be used in the development of early- and late-stage European biotechs.
VC Renaissance: Index Ventures spin off Medicxi launches GSK and J&J backed €210m fund 03-Feb-2016 By Gareth Macdonald Biologics developers backed by Medicxi Ventures’ new €210m ($229m) fund will use Lonza for contract manufacturing under an existing deal with Index Ventures.